Cancer therapeutics: reflections on natural killer cells.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 285, doi. 10.1002/ddr.20260
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2008 AND VI 69 AND IP 6
Results: 9
1
2
Top NOTCH targets: notch signaling in cancer.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 319, doi. 10.1002/ddr.20264
- By:
- Publication type:
- Article
3
EGFR inhibition in the treatment of non-small cell lung cancer.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 359, doi. 10.1002/ddr.20268
- By:
- Publication type:
- Article
4
New cancer drugs targeting the biosynthesis of estrogens and androgens.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 304, doi. 10.1002/ddr.20263
- By:
- Publication type:
- Article
5
Colchicine site inhibitors of microtubule integrity as vascular disrupting agents.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 352, doi. 10.1002/ddr.20267
- By:
- Publication type:
- Article
6
Carbonic anhydrase inhibitors: possible anticancer drugs with a novel mechanism of action.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 297, doi. 10.1002/ddr.20262
- By:
- Publication type:
- Article
7
Targeting tumor vascular endothelium: an emerging concept for cancer therapy.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 340, doi. 10.1002/ddr.20266
- By:
- Publication type:
- Article
8
New developments in small molecules targeting p53 pathways in anticancer therapy.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 289, doi. 10.1002/ddr.20261
- By:
- Publication type:
- Article
9
Integrin α<sub>v</sub>β<sub>3</sub>-targeted cancer therapy.
- Published in:
- Drug Development Research, 2008, v. 69, n. 6, p. 329, doi. 10.1002/ddr.20265
- By:
- Publication type:
- Article